Subsidy Information and Financing Scheme SDLCapecitabine Tablet 150 mg, 500 mg MSHLCapecitabine Tablet 150 mg, 500 mg For cancer treatment.
Post Marketing Information DHCPL 09/12/2013 Communication on the introduction of warnings and precautions for severe skin reactions with Xeloda® (capecitabine) DHCPL 06/03/2013 TYKERB© (lapatinib ditosylate monohydrate) – Comparative data have shown that Lapatinib based regimens are less effective than Herceptin© (trastuzumab) based regimens in certain settings
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Tablet 150 mg KK Women's and Children's Hospital Khoo Teck Puat Hospital National Cancer Centre Ng Teng Fong General Hospital National University Hospital Singapore General Hospital Tan Tock Seng Hospital Woodlands Health Campus Tablet 500 mg KK Women's and Children's Hospital Khoo Teck Puat Hospital National Cancer Centre Ng Teng Fong General Hospital National University Hospital Singapore General Hospital Tan Tock Seng Hospital Woodlands Health Campus
ORAL Select a brand starting with the letter: C I K X CAPETERO CAPECITABINE TABLETS 150MG [SIN14798P] CAPETERO CAPECITABINE TABLETS 500MG [SIN14799P] INCITABINE FILM COATED TABLET 150MG [SIN16264P] INCITABINE FILM COATED TABLET 500MG [SIN16265P] INTACAPE FILM COATED TABLET 150 MG [SIN15463P] See all INTACAPE FILM COATED TABLET 500 MG [SIN15464P] KAPETRAL FILM-COATED TABLET 150MG [SIN15368P] KAPETRAL FILM-COATED TABLET 500MG [SIN15369P] XELODA TABLETS 150 MG [SIN10678P] XELODA TABLETS 500 MG [SIN10677P]